USA - NYSE:USNA - US90328M1071 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to USNA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-27 | DA Davidson | Maintains | Neutral -> Neutral |
| 2025-01-02 | DA Davidson | Maintains | Neutral -> Neutral |
| 2024-10-23 | DA Davidson | Maintains | Neutral -> Neutral |
| 2024-07-25 | DA Davidson | Maintains | Neutral -> Neutral |
| 2024-05-07 | DA Davidson | Maintains | Neutral -> Neutral |
| 2024-02-22 | DA Davidson | Maintains | Neutral -> Neutral |
| 2023-10-25 | DA Davidson | Maintains | Neutral -> Neutral |
| 2023-04-26 | DA Davidson | Maintains | Neutral |
| 2023-02-13 | DA Davidson | Maintains | Neutral |
| 2022-10-27 | DA Davidson | Maintains | Neutral |
| 2022-07-28 | DA Davidson | Maintains | Neutral |
| 2022-07-12 | DA Davidson | Maintains | Neutral |
| 2022-07-07 | Jefferies | Downgrade | Hold -> Underperform |
| 2022-04-27 | DA Davidson | Maintains | Neutral |
| 2022-04-14 | DA Davidson | Initiate | Neutral |
| 2021-02-10 | Roth Capital | Maintains | Buy |
6 analysts have analysed USNA and the average price target is 39.78 USD. This implies a price increase of 107.35% is expected in the next year compared to the current price of 19.185.
The consensus rating for USANA HEALTH SCIENCES INC (USNA) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering USANA HEALTH SCIENCES INC (USNA) is 6.